Atlas Trials

Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED)

Clinical trial NCT00880568 · COMPLETED

Trial details

NCT number
NCT00880568
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
NeoplasmsMalignant
Start date
2009-04-01
Primary completion
2010-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.